O4I1

CAS No. 175135-47-4

O4I1( O4I1 | O4I-1 | O4I 1 )

Catalog No. M18127 CAS No. 175135-47-4

O4I1 is an effective Oct3/4 inducer.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 41 In Stock
25MG 78 In Stock
50MG 119 In Stock
100MG 206 In Stock
200MG 357 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    O4I1
  • Note
    Research use only, not for human use.
  • Brief Description
    O4I1 is an effective Oct3/4 inducer.
  • Description
    O4I1 is a potent inducer of Oct3/4. O4I1 enhanced Oct3/4 expression. O4I1 not only promoted expression and stabilization of Oct3/4 but also enhanced its transcriptional activity in diverse human somatic cells, implying the possible benefit from using this class of compounds in regenerative medicine. Reprogramming somatic cells into induced-pluripotent cells (iPSCs) provides new access to all somatic cell types for clinical application without any ethical controversy arising from the use of embryonic stem cells (ESCs).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    O4I1 | O4I-1 | O4I 1
  • Pathway
    Autophagy
  • Target
    Autophagy
  • Recptor
    OCT3| OCT4
  • Research Area
    Others-Field
  • Indication
    ——

Chemical Information

  • CAS Number
    175135-47-4
  • Formula Weight
    253.3
  • Molecular Formula
    C16H15NO2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : ≥ 38 mg/mL; 150.02 mM
  • SMILES
    COc1ccc(cc1)COc1ccc(cc1)CC#N
  • Chemical Name
    4-[(4-Methoxyphenyl)methoxy]benzeneacetonitrile

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Cheng X, et al. J Med Chem. 2015 Aug 13;58(15):5742-5750.
molnova catalog
related products
  • SLLN-15

    SLLN-15 (Autophagy inducer SLLN-15) is a potent, orally available inducer of autophagy that selectively activated cytostatic macroautophagy/autophagy in TNBC preclinical models.

  • XRK3F2 B

    XRK3F2 is an inhibitor of the p62-ZZ domain, blunts MM-induced Runx2 suppression in vitro, and induces new bone formation and remodeling in the presence of tumor in vivo.

  • GC7 Sulfate

    GC7 Sulfate is a potent inhibitor of deoxyhypusine synthase (DHS). Eukaryotic translation initiation factor 5A2 (eIF5A2) is the only known substrate for DHS, so GC7 inhibits the activation of eIF5A2 by inhibiting DHS activity.